NCT07543055 2026-04-21
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Regeneron Pharmaceuticals
Phase 1 Not yet recruiting
Regeneron Pharmaceuticals
Shanghai University of Traditional Chinese Medicine
National Taiwan University Hospital
Charite University, Berlin, Germany
Medical University of Vienna
Universitaire Ziekenhuizen KU Leuven